- Fund Type: Open-End Fund
- Objective: -
- Asset Class: -
- Geographic Focus: -
Harel 4D Global Medical
+ Add to WatchlistCLAL4GM:IT
115.08 ILs 0.000.00%As of 00:59:30 ET on 05/22/2013.
Snapshot for Harel 4D Global Medical (CLAL4GM)
| Year To Date: | +20.10% | 3-Month: | +13.44% | 3-Year: | - | 52-Week Range: | 95.82 - 115.08 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +3.81% | 1-Year: | - | 5-Year: | - | Beta vs TA-100: | - |
Fund Profile & Information for CLAL4GM
Harel 4D Global Medical is an open-end fund incorporated in Israel.
| Inception Date: | 08-15-2012 | Telephone: | 972-3-7616429 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | - | ||
Fundamentals for CLAL4GM
| NAV | (on 2013-05-22) 115.08 |
|---|---|
| Assets (M) | (on 2013-04-30) 3.70 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for CLAL4GM
No dividends reported
Fees & Expenses for CLAL4GM
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | - |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for CLAL4GM
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Novartis AG | 950 | 240,191 | 8.158% |
| Pfizer Inc | 2,300 | 233,910 | 7.945% |
| GlaxoSmithKline PLC | 1,100 | 187,038 | 6.353% |
| Roche Holding AG | 220 | 181,220 | 6.155% |
| Johnson & Johnson | 600 | 165,344 | 5.616% |
| Gilead Sciences Inc | 1,100 | 161,838 | 5.497% |
| Sanofi | 850 | 154,257 | 5.240% |
| Bristol-Myers Squibb Co | 1,050 | 141,466 | 4.805% |
| Bayer AG | 380 | 139,605 | 4.742% |
| Celgene Corp | 360 | 132,879 | 4.513% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page